Active	Status	Sponsor type	Region	Phase	Filter
13 Active 4 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Gupta, Gaurav
FREEDOM-1, NCT03995901: A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation	Terminated	3	15	US	FCR001, Cell based therapy, Allogeneic stem cell transplant	Talaris Therapeutics Inc.	Transplanted Organ Rejection	02/23	02/23
NCT06001320: De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Trans Recip	Recruiting	1	100	US	Letermovir 480 mg once daily, Historical/Control	Virginia Commonwealth University, Merck Sharp & Dohme LLC	Kidney Transplant; Complications, CMV	09/25	09/26
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/24	12/25
Durlik, Magdalena
NCT04239703: Trifecta-Kidney cfDNA-MMDx Study	Recruiting	N/A	300	Europe, Canada, US, RoW	MMDx, Prospera, transplant patient blood sample, HLA antibody	University of Alberta, Natera, Inc., One Lambda	Kidney Transplant Rejection	12/24	12/25